silicon has been researched along with 1-1-diphenyl-2-picrylhydrazyl* in 1 studies
1 other study(ies) available for silicon and 1-1-diphenyl-2-picrylhydrazyl
| Article | Year |
|---|---|
Silicon containing ibuprofen derivatives with antioxidant and anti-inflammatory activities: An in vivo and in silico study.
There are many chronic diseases related with inflammation. The chronic inflammation can produce other problems as cancer. Therefore, it is necessary to design drugs with better anti-inflammatory activity than those in the clinic. Likewise, these could be used in chronic treatments with minimum adverse effects. The amide or ester functionality in combination with the insertion of a silyl alkyl moiety is able to improve some drug properties. In this context, the evaluation of a group of silicon containing ibuprofen derivatives (SCIDs) as antioxidants and anti-inflammatory agents is reported. Antioxidant activity was evaluated by the 2,2-Diphenyl-1-picrylhydrazyl (DPPH⨪), 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic) acid (ABTS Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Benzothiazoles; Biphenyl Compounds; Catalytic Domain; Computer Simulation; Cyclooxygenase 2; Ibuprofen; Iron Chelating Agents; Male; Molecular Docking Simulation; Picrates; Rats; Rats, Wistar; Silicon; Sulfonic Acids | 2017 |